These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

679 related articles for article (PubMed ID: 23382540)

  • 1. Cardiopulmonary exercise testing reflects similar pathophysiology and disease severity in heart failure patients with reduced and preserved ejection fraction.
    Guazzi M; Labate V; Cahalin LP; Arena R
    Eur J Prev Cardiol; 2014 Jul; 21(7):847-54. PubMed ID: 23382540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physiological dead space and arterial carbon dioxide contributions to exercise ventilatory inefficiency in patients with reduced or preserved ejection fraction heart failure.
    Van Iterson EH; Johnson BD; Borlaug BA; Olson TP
    Eur J Heart Fail; 2017 Dec; 19(12):1675-1685. PubMed ID: 28990307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and Hemodynamic Correlates and Prognostic Value of VE/VCO
    Klaassen SHC; Liu LCY; Hummel YM; Damman K; van der Meer P; Voors AA; Hoendermis ES; van Veldhuisen DJ
    J Card Fail; 2017 Nov; 23(11):777-782. PubMed ID: 28736291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Value of Cardiopulmonary Exercise Testing in Heart Failure With Reduced, Midrange, and Preserved Ejection Fraction.
    Nadruz W; West E; Sengeløv M; Santos M; Groarke JD; Forman DE; Claggett B; Skali H; Shah AM
    J Am Heart Assoc; 2017 Oct; 6(11):. PubMed ID: 29089342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of abnormal heart rate recovery in patients with heart failure reduced and preserved ejection fraction.
    Cahalin LP; Arena R; Labate V; Bandera F; Guazzi M
    Eur J Prev Cardiol; 2014 Jul; 21(7):906-14. PubMed ID: 23335654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exercise ventilatory inefficiency in heart failure and chronic obstructive pulmonary disease.
    Smith JR; Van Iterson EH; Johnson BD; Borlaug BA; Olson TP
    Int J Cardiol; 2019 Jan; 274():232-236. PubMed ID: 30201380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of cardiopulmonary exercise testing in heart failure with preserved ejection fraction. The Henry Ford HospITal CardioPulmonary EXercise Testing (FIT-CPX) project.
    Shafiq A; Brawner CA; Aldred HA; Lewis B; Williams CT; Tita C; Schairer JR; Ehrman JK; Velez M; Selektor Y; Lanfear DE; Keteyian SJ
    Am Heart J; 2016 Apr; 174():167-72. PubMed ID: 26995385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A flattening oxygen consumption trajectory phenotypes disease severity and poor prognosis in patients with heart failure with reduced, mid-range, and preserved ejection fraction.
    Popovic D; Arena R; Guazzi M
    Eur J Heart Fail; 2018 Jul; 20(7):1115-1124. PubMed ID: 29405511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth differentiation factor 15, ST2, high-sensitivity troponin T, and N-terminal pro brain natriuretic peptide in heart failure with preserved vs. reduced ejection fraction.
    Santhanakrishnan R; Chong JP; Ng TP; Ling LH; Sim D; Leong KT; Yeo PS; Ong HY; Jaufeerally F; Wong R; Chai P; Low AF; Richards AM; Lam CS
    Eur J Heart Fail; 2012 Dec; 14(12):1338-47. PubMed ID: 22869458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-terminal pro brain natriuretic peptide-guided management in patients with heart failure and preserved ejection fraction: findings from the Trial of Intensified versus standard medical therapy in elderly patients with congestive heart failure (TIME-CHF).
    Maeder MT; Rickenbacher P; Rickli H; Abbühl H; Gutmann M; Erne P; Vuilliomenet A; Peter M; Pfisterer M; Brunner-La Rocca HP;
    Eur J Heart Fail; 2013 Oct; 15(10):1148-56. PubMed ID: 23657728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of Effort Intolerance in Patients With Heart Failure: Combined Echocardiography and Cardiopulmonary Stress Protocol.
    Shimiaie J; Sherez J; Aviram G; Megidish R; Viskin S; Halkin A; Ingbir M; Nesher N; Biner S; Keren G; Topilsky Y
    JACC Heart Fail; 2015 Oct; 3(10):803-14. PubMed ID: 26449998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The combined exercise stress echocardiography and cardiopulmonary exercise test for identification of masked heart failure with preserved ejection fraction in patients with hypertension.
    Nedeljkovic I; Banovic M; Stepanovic J; Giga V; Djordjevic-Dikic A; Trifunovic D; Nedeljkovic M; Petrovic M; Dobric M; Dikic N; Zlatar M; Beleslin B
    Eur J Prev Cardiol; 2016 Jan; 23(1):71-7. PubMed ID: 26358991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiopulmonary exercise testing as prognostic indicators: Comparisons among heart failure patients with reduced, mid-range and preserved ejection fraction.
    Sato T; Yoshihisa A; Kanno Y; Suzuki S; Yamaki T; Sugimoto K; Kunii H; Nakazato K; Suzuki H; Saitoh SI; Ishida T; Takeishi Y
    Eur J Prev Cardiol; 2017 Dec; 24(18):1979-1987. PubMed ID: 29086584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Explanation of the variance in quality of life and activity capacity of patients with heart failure by laboratory data.
    Athanasopoulos LV; Dritsas A; Doll HA; Cokkinos DV
    Eur J Cardiovasc Prev Rehabil; 2010 Aug; 17(4):375-9. PubMed ID: 19940776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heart Failure and Midrange Ejection Fraction: Implications of Recovered Ejection Fraction for Exercise Tolerance and Outcomes.
    Nadruz W; West E; Santos M; Skali H; Groarke JD; Forman DE; Shah AM
    Circ Heart Fail; 2016 Apr; 9(4):e002826. PubMed ID: 27009553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction: Association With Exercise Capacity, Left Ventricular Filling Pressures, Natriuretic Peptides, and Left Atrial Volume.
    Lam CS; Rienstra M; Tay WT; Liu LC; Hummel YM; van der Meer P; de Boer RA; Van Gelder IC; van Veldhuisen DJ; Voors AA; Hoendermis ES
    JACC Heart Fail; 2017 Feb; 5(2):92-98. PubMed ID: 28017355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional iron deficiency and diastolic function in heart failure with preserved ejection fraction.
    Kasner M; Aleksandrov AS; Westermann D; Lassner D; Gross M; von Haehling S; Anker SD; Schultheiss HP; Tschöpe C
    Int J Cardiol; 2013 Oct; 168(5):4652-7. PubMed ID: 23968714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-1 Blockade in Patients With Heart Failure With Preserved Ejection Fraction.
    Van Tassell BW; Trankle CR; Canada JM; Carbone S; Buckley L; Kadariya D; Del Buono MG; Billingsley H; Wohlford G; Viscusi M; Oddi-Erdle C; Abouzaki NA; Dixon D; Biondi-Zoccai G; Arena R; Abbate A
    Circ Heart Fail; 2018 Aug; 11(8):e005036. PubMed ID: 30354558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adaptive cardiovascular hormones in a spectrum of heart failure phenotypes.
    Zabarovskaja S; Hage C; Linde C; Daubert JC; Donal E; Gabrielsen A; Mellbin L; Lund LH
    Int J Cardiol; 2015; 189():6-11. PubMed ID: 25885866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are existing and emerging biomarkers associated with cardiorespiratory fitness in patients with chronic heart failure?
    Fudim M; Kelly JP; Jones AD; AbouEzzeddine OF; Ambrosy AP; Greene SJ; Reddy YNV; Anstrom KJ; Alhanti B; Lewis GD; Hernandez AF; Felker GM
    Am Heart J; 2020 Feb; 220():97-107. PubMed ID: 31805424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.